Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands		Total	Common Shares	Class B Common Stock	Common Stock Common Shares	Common Stock Class B Common Stock	Capital Surplus	Retained Earnings	Retained Earnings Common Shares	Retained Earnings Class B Common Stock	Accumulated Other Comprehensive Loss
Balance at beginning of period at Aug. 29, 2020		$ 1,741,129			$ 1,525	$ 364	$ 86,645	$ 1,684,565			$ (31,970)
Balance at beginning of period (in shares) at Aug. 29, 2020					15,251	3,643
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		41,896						41,896
Change in fair value of derivatives		(21)									(21)
Foreign currency translation		1,310									1,310
Dividends declared Common Stock			$ (3,806)	$ (729)					$ (3,806)	$ (729)
Repurchase of Common Stock		(7,216)			$ (4)		(223)	(6,989)
Repurchase of common stock (in shares)					(41)
Share-based compensation, net	[1]	788					788
Share-based awards exercised, net	[2]	1			$ 1
Share-based awards exercised, net (in shares)	[2]				11
Balance at end of period at Nov. 28, 2020		1,773,352			$ 1,522	$ 364	87,210	1,714,937			(30,681)
Balance at end of period (in shares) at Nov. 28, 2020					15,221	3,643
Balance at beginning of period at Aug. 29, 2020		1,741,129			$ 1,525	$ 364	86,645	1,684,565			(31,970)
Balance at beginning of period (in shares) at Aug. 29, 2020					15,251	3,643
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		74,481
Foreign currency translation		3,554
Balance at end of period at Feb. 27, 2021		1,801,110			$ 1,523	$ 364	86,979	1,740,737			(28,493)
Balance at end of period (in shares) at Feb. 27, 2021					15,230	3,643
Balance at beginning of period at Nov. 28, 2020		1,773,352			$ 1,522	$ 364	87,210	1,714,937			(30,681)
Balance at beginning of period (in shares) at Nov. 28, 2020					15,221	3,643
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		32,585						32,585
Change in fair value of derivatives		(56)									(56)
Foreign currency translation		2,244									2,244
Dividends declared Common Stock			(3,806)	(728)					(3,806)	(728)
Repurchase of Common Stock		(2,318)			$ (1)		(66)	(2,251)
Repurchase of common stock (in shares)					(12)
Share-based compensation, net	[1]	(165)					(165)
Share-based awards exercised, net	[2]	2			$ 2
Share-based awards exercised, net (in shares)	[2]				21
Balance at end of period at Feb. 27, 2021		1,801,110			$ 1,523	$ 364	86,979	1,740,737			(28,493)
Balance at end of period (in shares) at Feb. 27, 2021					15,230	3,643
Balance at beginning of period at Aug. 28, 2021		1,872,952			$ 1,524	$ 364	89,257	1,806,643			(24,836)
Balance at beginning of period (in shares) at Aug. 28, 2021					15,236	3,643
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		33,705						33,705
Change in fair value of derivatives		47									47
Foreign currency translation		(2,799)									(2,799)
Dividends declared Common Stock			(4,566)	(874)					(4,566)	(874)
Repurchase of Common Stock		(4,771)			$ (2)		(124)	(4,645)
Repurchase of common stock (in shares)					(23)
Share-based compensation, net	[1]	1,207					1,207
Share-based awards exercised, net (in shares)	[2]				7
Balance at end of period at Nov. 27, 2021		1,894,901			$ 1,522	$ 364	90,340	1,830,263			(27,588)
Balance at end of period (in shares) at Nov. 27, 2021					15,220	3,643
Balance at beginning of period at Aug. 28, 2021		1,872,952			$ 1,524	$ 364	89,257	1,806,643			(24,836)
Balance at beginning of period (in shares) at Aug. 28, 2021					15,236	3,643
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		52,156
Foreign currency translation		(1,650)
Balance at end of period at Feb. 26, 2022		1,898,975			$ 1,521	$ 363	90,006	1,833,579			(26,494)
Balance at end of period (in shares) at Feb. 26, 2022					15,209	3,626
Balance at beginning of period at Nov. 27, 2021		1,894,901			$ 1,522	$ 364	90,340	1,830,263			(27,588)
Balance at beginning of period (in shares) at Nov. 27, 2021					15,220	3,643
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		18,451						18,451
Change in fair value of derivatives		(55)									(55)
Foreign currency translation		1,149									1,149
Dividends declared Common Stock			$ (4,561)	$ (870)					$ (4,561)	$ (870)
Repurchase of Common Stock		(9,995)			$ (5)		(286)	(9,704)
Repurchase of common stock (in shares)					(53)
Share-based compensation, net	[1]	(48)					(48)
Share-based awards exercised, net	[2]	3			$ 3
Share-based awards exercised, net (in shares)	[2]				25
Shares converted					$ 1	$ (1)
Shares converted (in shares)					17	(17)
Balance at end of period at Feb. 26, 2022		$ 1,898,975			$ 1,521	$ 363	$ 90,006	$ 1,833,579			$ (26,494)
Balance at end of period (in shares) at Feb. 26, 2022					15,209	3,626

[1] These amounts are shown net of any shares withheld by the Company to satisfy certain tax withholding obligations in connection with the vesting of certain restricted stock units.

[2] These amounts are shown net of the effect of income taxes.